The CEO's $9M Check Meets a Track Record That Stings

ISB Research · Favorable · sent to Ultimate members August 5, 2026

Mike Mahoney runs Boston Scientific, and he just put $9 million to work at $48.33 with two other insiders buying alongside him in the past month. That's the kind of cluster you want to see from the top of the org chart. But the history here is ugly. The last six insider buys on this name averaged a 14% loss over the next 30 days, badly trailing the market, so this CEO's read hasn't paid off recently. The chart is more encouraging, with the 8-day crossing above the 20-day five days back and momentum building underneath, so if you want a defined-risk way to lean in, the September 45/40 put spread pays about 90 cents with a 71% shot at keeping it and gets you positioned under his buy price.

Ultimate members received this analysis in real time.